Page results
-
The TB network for north central London aims to reduce the capital’s high number of new cases and making it easier for patients to receive treatment.
-
The COVID Medicines Delivery Unit (CMDU gives new COVID-19 treatments for patients at highest risk in the community from the NCL sector. These treatments involve intravenous infustion of neutralising monoclonal antibodies (nMABs) or oral antiviral treatments, which are given to high-risk patients who have had a positive PCR test.
-
This page, written by the Physiotherapy Services at the Royal London Hospital for Integrated Medicine, is intended for patients (or their family or carers) who have been referred to the clinic.
-
This information is for patients who are having radiotherapy to the pelvis.
-
UCLH provides a comprehensive service to diagnose, treat and support people with cancer. We are a specialist centre for many types of cancer and treat patients from both our local area and across the country.
-
The lymphoedema service at UCLH provides assessment, diagnosis, treatment and management of cancer-related lymphoedema.
-
The Preterm Birth Clinic is one of a few UK specialist antenatal services that are designed specifically for the needs of pregnant women at risk of premature labour.
-
The Central Venous Access Device team provides a nurse-led service to teenagers and adults who have been referred to UCLH for cancer treatment.
-
At UCLH we use many different drugs to treat patients with cancer. Chemotherapy is the treatment of cancer with drugs designed to control or destroy the growth of the tumour.
-
UCLH is a specialist centre for the treatment of urological cancers.
File results
-
FOI/2023/0475 - Agency usage for the decontamination department
-
FOI/2023/0476 - Single longest wait in A&E for mental health related issue
-
FOI/2023/0478 - Social media management platform
-
FOI/2024/0481 - Maternity unit closed to new admissions 2018-2023
-
FOI/2023/0481 - Closure of maternity unit to new admissions 2018/23
-
FOI/2023/0485 - Heart attacks 2019/22
-
FOI/2023/0487 - Maintenance of corporate estate
-
FOI/2023/0488 - Electronic Patient Record (EPR)
-
FOI/2023/0491 - Treatment for oesophageal and gastric cancer
-
FOI/2023/0493 - Treatments for various diseases